Unravelling the Measles Paradox in Children
NCT06923631 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-11-26
Summary
Measles is caused by measles virus (MeV). The disease is associated with lymphopenia and immune suppression, which is an important cause of measles-associated morbidity and mortality. Measles-induced immune suppression can last several years, whereas measles lymphopenia is usually resolved within two weeks. At the same time, measles induces lifelong immunity. This apparent contradiction, known as the 'measles paradox', was partially solved when investigators demonstrated that MeV infects and depletes pre-existing memory cells, thereby causing 'immune amnesia'. This model is supported by observations in animal models and clinical studies, but several questions remain to be addressed, like the duration of measles-induced amnesia and changes in the immune repertoire after measles. to address the immunological questions regarding MeV infection.
Conditions
- MEASLES DISEASE
Sponsors & Collaborators
- lead OTHER
Eligibility
- Min Age
- 4 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-01-03
- Primary Completion
- 2029-04-01
- Completion
- 2029-04-01
Countries
- Netherlands
Study Locations
More Related Trials
-
Impact of HIV on Measles and Measles Immunisation
NCT00247091 ·Status: COMPLETED
-
A Second Dose of Measles Vaccine (MV) in the Second Year of Life
NCT02943681 ·Status: COMPLETED ·Phase: NA
-
Measles, Mumps, and Rubella (MMR) Immunity in College Students
NCT00962819 ·Status: COMPLETED
-
Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years
NCT00891007 ·Status: COMPLETED ·Phase: PHASE2
-
Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children
NCT03460002 ·Status: COMPLETED ·Phase: PHASE4
-
Additional Measles Vaccine at 4 Months of Age
NCT01486355 ·Status: UNKNOWN ·Phase: PHASE4
-
Measles Vaccination at Health System Contacts
NCT04220671 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Measles Vaccine in HCW
NCT04357028 ·Status: SUSPENDED ·Phase: PHASE3
-
Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings
NCT06667206 ·Status: RECRUITING ·Phase: PHASE2
-
Non-Specific Effects of Standard Titre Measles Vaccination
NCT00168662 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of Immune Amnesia Following Measles Infection in Select African Regions
NCT06153979 ·Status: COMPLETED
-
Long-term Follow-up of Measles Antibodies
NCT00168571 ·Status: COMPLETED ·Phase: PHASE4
-
Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed
NCT05592756 ·Status: COMPLETED
-
Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?
NCT04445610 ·Status: UNKNOWN
-
Immunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccine (Measles, Mumps and Rubella)
NCT05154097 ·Status: UNKNOWN
-
Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.
NCT01668745 ·Status: COMPLETED ·Phase: PHASE4
-
Immunology of Non-specific Effects of Vaccine
NCT00168545 ·Status: COMPLETED ·Phase: PHASE4
-
Trial of Additional Measles Vaccine to Reduce Child Mortality
NCT01644721 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Study of Not Giving Diphteria-tetanus-pertussis Vaccination With or After Measles Vaccination
NCT00244673 ·Status: COMPLETED ·Phase: PHASE4
-
Prophylactic Antibiotics in Measles
NCT00168532 ·Status: COMPLETED ·Phase: PHASE3
-
Barriers and Facilitators to MMR Vaccination Among Healthcare Workers
NCT06456788 ·Status: COMPLETED
-
Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination
NCT00804219 ·Status: COMPLETED ·Phase: PHASE4
-
Measles and BCG Vaccines for Mother and Child
NCT04899765 ·Status: RECRUITING ·Phase: PHASE4
-
Impact of Helminth Infections During Pregnancy on Humoral Vaccine Immunogenicity in Infants
NCT02714348 ·Status: UNKNOWN
-
Evaluation of Pediatric Measles Cases in 2019: Single-Center Experience
NCT05614791 ·Status: COMPLETED